http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#head
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#provenance
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/2099
http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0006142
http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#provenance
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://purl.org/dc/terms/description
[We analyzed three series of de novo stage II-III breast cancer patients treated front line with anthracycline-based regimens of various cyclophosphamide dose intensities: 65 patients with estrogen receptor (ER)(-) tumors treated with anthracyclines alone (Institut Jules Bordet, Brussels), 51 unselected breast cancer patients treated with intermediate doses of cyclophosphamide (MD Anderson Cancer Center, Houston, TX), and 128 others treated with a dose-dense anthracycline-cyclophosphamide combination (St. Louis, Paris).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/20228131
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/dc/terms/created
2017-10-17T13:12:29+02:00
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0